Valuation : Novartis AG

Market Cap 31TCr 5,20300Cr 26TCr 25TCr 23TCr 43TCr 29,11500Cr 43TCr 2,94300Cr 1,14500Cr 14,81000Cr 1,15200Cr 1,12700Cr 49,10700Cr P/E 2026 *
22.9x
P/E 2027 * 19.5x
Enterprise Value 34TCr 5,75800Cr 29TCr 28TCr 25TCr 47TCr 32,21600Cr 47TCr 3,25600Cr 1,26700Cr 16,38800Cr 1,27400Cr 1,24700Cr 54,33900Cr EV / Sales 2026 *
5.89x
EV / Sales 2027 * 5.46x
Free-Float
91.66%
Yield 2026 *
2.71%
Yield 2027 * 2.82%
1 day+6.29%
1 week+1.44%
Current month+6.29%
1 month+1.40%
3 months+5.45%
6 months-3.75%
Current year+9.92%
1 week 2,585.5
Extreme 2585.5
2,748
1 month 2,585.5
Extreme 2585.5
2,748
Current year 2,479
Extreme 2479
2,866.83
1 year 2,254.9
Extreme 2254.9
2,866.83
3 years 1,540
Extreme 1540
2,866.83
5 years 1,520
Extreme 1520
2,866.83
10 years 1,320.81
Extreme 1320.81
2,866.83
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
+6.29%+1.44% - - 29TCr
+0.28%-5.97%+58.34%+108.22% 1,03100Cr
+2.01%-0.71%+53.07%+68.99% 64TCr
+1.39%-2.18%+23.57%+75.43% 45TCr
-1.50%-7.04%+33.55%+33.94% 35TCr
+6.25%+2.04%+28.97%+46.57% 29TCr
-0.07%-4.12%+0.95%+11.79% 25TCr
+1.92%-0.93%+52.28%+70.67% 23TCr
+0.51%-4.52%-19.50%-54.83% 20TCr
+2.45%+0.77%+32.71%+95.59% 18TCr
Average +2.08%-2.91%+29.33%+50.71% 40.33TCr
Weighted average by Cap. +1.95%-3.40%+38.39%+66.40%

Financials

2026 *2027 *
Net sales 5.76TCr 98TCr 4.97TCr 4.68TCr 4.26TCr 8.01TCr 5,47100Cr 8.06TCr 55TCr 22TCr 2,78300Cr 22TCr 21TCr 9,22800Cr 6.13TCr 1,04000Cr 5.29TCr 4.97TCr 4.53TCr 8.52TCr 5,81900Cr 8.57TCr 59TCr 23TCr 2,96000Cr 23TCr 23TCr 9,81400Cr
Net income 1.4TCr 24TCr 1.2TCr 1.13TCr 1.03TCr 1.94TCr 1,32400Cr 1.95TCr 13TCr 5.21TCr 67TCr 5.24TCr 5.12TCr 2,23300Cr 1.55TCr 26TCr 1.34TCr 1.26TCr 1.15TCr 2.15TCr 1,47100Cr 2.17TCr 15TCr 5.79TCr 75TCr 5.82TCr 5.69TCr 2,48200Cr
Net Debt 3.27TCr 55TCr 2.82TCr 2.65TCr 2.42TCr 4.54TCr 3,10200Cr 4.57TCr 31TCr 12TCr 1,57800Cr 12TCr 12TCr 5,23100Cr 2.78TCr 47TCr 2.4TCr 2.26TCr 2.06TCr 3.87TCr 2,64000Cr 3.89TCr 27TCr 10TCr 1,34300Cr 10TCr 10TCr 4,45300Cr
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
01/26/01 MX$2,748.00 +6.29% 27
31/26/31 MX$2,585.50 -2.80% 198
28/26/28 MX$2,660.00 -0.71% 173
26/26/26 MX$2,679.00 -1.11% 71
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
161.40USD
Average target price
154.40USD
Spread / Average Target
-4.33%

Quarterly revenue - Rate of surprise